Book a Meeting

Anti-Human PD-L1 Fc Silent Antibody, Clone CD73.4 (CAT#: CB-LX079-A) Datasheet

Product Type
Antibody
Description
Anti-Human PD-L1-Fc silent antibody is derived from clone CD73.4, which is a Human monoclonal antibody targeting the PD-L1. And it is intended for the research of Metastatic melanoma, metastatic NSCLC.
Research Area
Cell Biology, Immunology,
Antigen Distribution
Broad expression in appendix (RPKM 6.7), placenta (RPKM 4.5) and 23 other tissues.
Disease
Metastatic melanoma, metastatic NSCLC
Size
100 ug
Immunogen
Recombinant Human PD-L1 protein
Species
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1-IgG2 chimera
Clone Number
CD73.4
Conjugation
Unconjugated
Source
Recombinant
Buffer
PBS, pH 7.4
Application
Block
Application Notes
The use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution.
Handling Advice
This product is for research use only. It is not intended for use in therapeutic or diagnostic procedures for humans or animals.
Storage Instructions
Product should be stored at -80°C. Repeated freeze and thaw cycles will cause loss of activity. Use product within 24 hours after thawing and keep on ice. Remainder amounts should be aliquoted and immediately re-freezed for future use. Aliquots should never be thawed more than once. Under recommended storage conditions, product is stable for at least one year.
Target
PD-L1
Official Name
CD274 molecule
Full Name
CD274 molecule
Background
This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Alternative Names
CD274 molecule
Gene ID
Uniprot ID

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.